Based on this data and data from two other Phase III trials, Takeda will file for the approval of zasocitinib in PsA.

Bristol-Myers (BMY) stock is in focus as a psoriasis therapy from Takeda (TAK) outperforms the company's FDA approved therapy Sotyktu in a late-stage trial. Read more here.

The Pasco Sheriff’s Office, New Port Richey Police Department, Florida Fish and Wildlife Conservation Commission, and U.S.

Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the Phase 3, randomized, multicenter, ...

Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly ...

Takeda announces zasocitinib significantly outperforms deucravacitinib in head-to-head phase 3 psoriasis study: Osaka, Japan Saturday, June 13, 2026, 12:00 Hrs [IST] Takeda announ ...

Which is better as an anime MMO: Blue Protocol or PSO2? Let's discuss it (Image via A-Plus & SEGA) PSO2 now has some competition, thanks to Blue Protocol Star Resonance finally hitting the anime MMO ...

56-year-old Michael Greenleaf is accused of being responsible for the death of his mother, Carolyn, along with her suffering ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Pearson (FTSE: PSON.L) announced the winners of the 24th annual Certiport 2026 Microsoft Office Specialist U.S. National ...

On July 16, 1978, six employees at the Sirloin Stockade in Oklahoma City were murdered by Roger Dale Stafford, his wife, ...

Union Education Minister Dharmendra Pradhan chaired a high-level review meeting with senior officials from the Ministry of Education, state government ...